Xinglong Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xinglong Zhu has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Ji Bao
Department of Pathology, Institute of Clinical Pathology, Key Laboratory of Transplant Engineering and Immunology, NHC, West China Hospital, Sichuan University, Chengdu, China
2 shared publications - Jie Zhang
Shanghai Jiao Tong University
2 shared publications - Min Chen
Shanghai Jiao Tong University
2 shared publications - Su-Ming Weng
Shanghai Jiao Tong University
2 shared publications - Wei-Yuan Liu
Key Laboratory for Laser Plasmas (MoE), School of Physics and Astronomy, Shanghai Jiao Tong University, Shanghai 200240, China
2 shared publications - Yi Li
Institute of Respiratory Health and Multimorbidity, Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041, China
2 shared publications
Latest Publications
- Open Access
- 30 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (17) , 6742
Composition and Function of Decellularized Human Lung Extracellular Matrix from Congenital Pulmonary Airway Malformation
Background: Congenital pulmonary airway malformation (CPAM) is a rare developmental disorder characterized by cystic lung lesions, yet its extracellular matrix (ECM) composition remains poorly understood. This study employed decellularization and data-independent acquisition (DIA) proteomics to compare ECM profiles between cystic (CPAM) and histologically normal non-diseased (ND) regions from the lungs of four patients. Results: The decellularized scaffolds retained their native architecture with minimal residual DNA (<50 ng/mg). Proteomic analysis revealed 431 differentially expressed proteins (DEPs), with 171 upregulated and 260 downregulated in CPAM. Key findings revealed CPAM-specific enrichment of collagens (COL4A6, COL4A2, COL10A1, COL21A1 and PIIINP), glycoproteins (SPP1, FRAS1, FREM1, FREM2, LTBP1 and FBLN7), ECM regulators (TENM2, ROR2 and OMD), and ECM-affiliated proteins (ANXA7), alongside downregulation of glycoproteins (VASN and ABI3BP), proteoglycans (PODN and MXRA7), ECM regulators (SCARA5, PAPPA, SAA4, CPXM1, CTSC, THY1, SERPINA6/A1/D1, BSG, LYVE1, ITIH4 and CD44), and ECM-affiliated proteins (LGALSL). Pathway analysis highlighted the dysregulation of TGF-β, PI3K–AKT, and mTOR signaling in CPAM and aberrant ECM–cell interactions in pathogenesis. We also evaluated their functional properties and investigated the impact of ECM-based hydrogels on recellularization. Conclusions: These findings provide a comprehensive proteomic atlas of CPAM ECM alterations, offering insights into disease mechanisms and potential therapeutic targets.
- 30 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (17) , 6742
Open AccessComposition and Function of Decellularized Human Lung Extracellular Matrix from Congenital Pulmonary Airway Malformation
Background: Congenital pulmonary airway malformation (CPAM) is a rare developmental disorder characterized by cystic lung lesions, yet its extracellular matrix (ECM) composition remains poorly understood. This study employed decellularization and data-independent acquisition (DIA) proteomics to compare ECM profiles between cystic (CPAM) and histologically normal non-diseased (ND) regions from the lungs of four patients. Results: The decellularized scaffolds retained their native architecture with minimal residual DNA (<50 ng/mg). Proteomic analysis revealed 431 differentially expressed proteins (DEPs), with 171 upregulated and 260 downregulated in CPAM. Key findings revealed CPAM-specific enrichment of collagens (COL4A6, COL4A2, COL10A1, COL21A1 and PIIINP), glycoproteins (SPP1, FRAS1, FREM1, FREM2, LTBP1 and FBLN7), ECM regulators (TENM2, ROR2 and OMD), and ECM-affiliated proteins (ANXA7), alongside downregulation of glycoproteins (VASN and ABI3BP), proteoglycans (PODN and MXRA7), ECM regulators (SCARA5, PAPPA, SAA4, CPXM1, CTSC, THY1, SERPINA6/A1/D1, BSG, LYVE1, ITIH4 and CD44), and ECM-affiliated proteins (LGALSL). Pathway analysis highlighted the dysregulation of TGF-β, PI3K–AKT, and mTOR signaling in CPAM and aberrant ECM–cell interactions in pathogenesis. We also evaluated their functional properties and investigated the impact of ECM-based hydrogels on recellularization. Conclusions: These findings provide a comprehensive proteomic atlas of CPAM ECM alterations, offering insights into disease mechanisms and potential therapeutic targets.
- Open Access
- 18 March 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (3) , 984
The CRISPR/Cas9 System Delivered by Extracellular Vesicles
Clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein (Cas) systems can precisely manipulate DNA sequences to change the characteristics of cells and organs, which has potential in the mechanistic research on genes and the treatment of diseases. However, clinical applications are restricted by the lack of safe, targeted and effective delivery vectors. Extracellular vesicles (EVs) are an attractive delivery platform for CRISPR/Cas9. Compared with viral and other vectors, EVs present several advantages, including safety, protection, capacity, penetrating ability, targeting ability and potential for modification. Consequently, EVs are profitably used to deliver the CRISPR/Cas9 in vivo. In this review, the advantages and disadvantages of the delivery form and vectors of the CRISPR/Cas9 are concluded. The favorable traits of EVs as vectors, such as the innate characteristics, physiological and pathological functions, safety and targeting ability of EVs, are summarized. Furthermore, in terms of the delivery of the CRISPR/Cas9 by EVs, EV sources and isolation strategies, the delivery form and loading methods of the CRISPR/Cas9 and applications have been concluded and discussed. Finally, this review provides future directions of EVs as vectors of the CRISPR/Cas9 system in clinical applications, such as the safety, capacity, consistent quality, yield and targeting ability of EVs.
- 18 March 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (3) , 984
Open AccessThe CRISPR/Cas9 System Delivered by Extracellular Vesicles
Clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein (Cas) systems can precisely manipulate DNA sequences to change the characteristics of cells and organs, which has potential in the mechanistic research on genes and the treatment of diseases. However, clinical applications are restricted by the lack of safe, targeted and effective delivery vectors. Extracellular vesicles (EVs) are an attractive delivery platform for CRISPR/Cas9. Compared with viral and other vectors, EVs present several advantages, including safety, protection, capacity, penetrating ability, targeting ability and potential for modification. Consequently, EVs are profitably used to deliver the CRISPR/Cas9 in vivo. In this review, the advantages and disadvantages of the delivery form and vectors of the CRISPR/Cas9 are concluded. The favorable traits of EVs as vectors, such as the innate characteristics, physiological and pathological functions, safety and targeting ability of EVs, are summarized. Furthermore, in terms of the delivery of the CRISPR/Cas9 by EVs, EV sources and isolation strategies, the delivery form and loading methods of the CRISPR/Cas9 and applications have been concluded and discussed. Finally, this review provides future directions of EVs as vectors of the CRISPR/Cas9 system in clinical applications, such as the safety, capacity, consistent quality, yield and targeting ability of EVs.
- Open Access
Tail-wave-assisted Positron Acceleration in Nonlinear Laser Plasma Wakefields
Relativistic laser wakefield acceleration is characterized by an unsurpassed accelerating gradient, which is very suitable for electron acceleration over short distances and could be a promising candidate for next-generation compact accelerators. However, using this technique for positron acceleration is still challenging because positively charged particles are naturally defocused in nonlinear wakefields. Here we propose and numerically demonstrate a scheme to accelerate an externally injected positron beam in a nonlinear laser wakefield in a regime where a tail wave is formed behind density cusps of the wakefield. This tail wave can provide a focusing force in addition to longitudinal acceleration for the positrons. Three-dimensional particle-in-cell simulations demonstrate that a trapping efficiency of positrons of nearly 100% in the nonlinear wakefield is possible. This scheme may open a simple way for compact positron acceleration to multi-100 MeV with terawatt-class laser systems at high repetition rates without the need for special laser modes and plasma structures.
Open AccessTail-wave-assisted Positron Acceleration in Nonlinear Laser Plasma Wakefields
Relativistic laser wakefield acceleration is characterized by an unsurpassed accelerating gradient, which is very suitable for electron acceleration over short distances and could be a promising candidate for next-generation compact accelerators. However, using this technique for positron acceleration is still challenging because positively charged particles are naturally defocused in nonlinear wakefields. Here we propose and numerically demonstrate a scheme to accelerate an externally injected positron beam in a nonlinear laser wakefield in a regime where a tail wave is formed behind density cusps of the wakefield. This tail wave can provide a focusing force in addition to longitudinal acceleration for the positrons. Three-dimensional particle-in-cell simulations demonstrate that a trapping efficiency of positrons of nearly 100% in the nonlinear wakefield is possible. This scheme may open a simple way for compact positron acceleration to multi-100 MeV with terawatt-class laser systems at high repetition rates without the need for special laser modes and plasma structures.
- Open Access
Bunched proton acceleration from a laser-irradiated cone target
Laser-driven ion acceleration is an attractive technique for compact high-energy ion sources. Currently, among various physical and technical issues to be solved, the boost of ion energy and the reduction of energy spread represent the key challenges with this technique. Here we present a scheme to tackle these challenges by using a hundred-terawatt-class laser pulse irradiating a cone target. Three-dimensional particle-in-cell simulations show that a large number of electrons are dragged out of the cone walls and accelerated to hundreds of MeV by the laser fields inside the cone. When these energetic dense electron beams pass through the cone target tip into vacuum, a very high bunching acceleration field, up to tens of TV/m, quickly forms. Protons are accelerated and simultaneously bunched by this field, resulting in quasi-monoenergetic proton beams with hundred MeV energy and low energy spread of ~2%. Results exploring the scaling of the proton beam energy with laser and target parameters are presented, indicating that the scheme is robust. This opens a new route for compact high-energy proton sources from fundamental research to biomedical applications.
Open AccessBunched proton acceleration from a laser-irradiated cone target
Laser-driven ion acceleration is an attractive technique for compact high-energy ion sources. Currently, among various physical and technical issues to be solved, the boost of ion energy and the reduction of energy spread represent the key challenges with this technique. Here we present a scheme to tackle these challenges by using a hundred-terawatt-class laser pulse irradiating a cone target. Three-dimensional particle-in-cell simulations show that a large number of electrons are dragged out of the cone walls and accelerated to hundreds of MeV by the laser fields inside the cone. When these energetic dense electron beams pass through the cone target tip into vacuum, a very high bunching acceleration field, up to tens of TV/m, quickly forms. Protons are accelerated and simultaneously bunched by this field, resulting in quasi-monoenergetic proton beams with hundred MeV energy and low energy spread of ~2%. Results exploring the scaling of the proton beam energy with laser and target parameters are presented, indicating that the scheme is robust. This opens a new route for compact high-energy proton sources from fundamental research to biomedical applications.
- 19 February 2009
- Published by IOP Publishing in Journal of Physics D: Applied Physics
- Vol. 42 (5) , 055411
Tensile and fatigue properties of ultrafine Cu–Ni multilayers
- 19 February 2009
- Published by IOP Publishing in Journal of Physics D: Applied Physics
- Vol. 42 (5) , 055411
Tensile and fatigue properties of ultrafine Cu–Ni multilayers